AG
Artal Group Portfolio holdings
AUM
$930M
This Quarter Return
-2.15%
1 Year Return
-3.57%
3 Year Return
+157.23%
5 Year Return
+160.22%
10 Year Return
+1,359.85%
AUM
$1.36B
AUM Growth
+$1.36B
(-5.9%)
Cap. Flow
-$23.4M
Cap. Flow
% of AUM
-1.72%
Top 10 Holdings %
Top 10 Hldgs %
86.25%
Holding
89
New
7
Increased
16
Reduced
1
Closed
9
Top Buys
| 1 |
Amazon
AMZN
|
$16.2M |
| 2 |
Incyte
INCY
|
$15.8M |
| 3 |
AUXL
AUXILIUM PHARAMCEUTICALS INC
AUXL
|
$12.8M |
| 4 |
Ionis Pharmaceuticals
IONS
|
$12.2M |
| 5 |
AVNR
AVANIR PHARMACEUTICALS, INC CL A
AVNR
|
$6.2M |
Top Sells
| 1 |
FURX
FURIEX PHARMACEUTICALS INC COM STK (DE)
FURX
|
$69.5M |
| 2 |
Amgen
AMGN
|
$18.5M |
| 3 |
Dollar General
DG
|
$13.9M |
| 4 |
MJN
Mead Johnson Nutrition Company
MJN
|
$12.5M |
| 5 |
BRF SA
BRFS
|
$8.93M |
Sector Composition
| 1 | Consumer Discretionary | 45.67% |
| 2 | Healthcare | 44.28% |
| 3 | Financials | 2.04% |
| 4 | Industrials | 0.98% |
| 5 | Technology | 0.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
WW
1
DELISTED
WW International
WW
| $580M | 23.44% | 28,749,089 | – | – |
|
2
Lexicon Pharmaceuticals
LXRX
$400M
| $408M | 16.49% | 253,372,135 | – | – |
|
|
AUXL
3
DELISTED
AUXILIUM PHARAMCEUTICALS INC
AUXL
| $40.4M | 1.63% | 2,015,000 +640,000 | +47% | +$12.8M |
|
4
BioMarin Pharmaceuticals
BMRN
$11.2B
| $32.7M | 1.32% | 525,000 | – | – |
|
|
PCYC
5
DELISTED
PHARMACYCLICS INC
PCYC
| $24.2M | 0.98% | 270,000 +60,000 | +29% | +$5.38M |
|
|
6
Incyte
INCY
$16.5B
| $21.4M | 0.87% | 380,000 +280,000 | +280% | +$15.8M |
|
7
Alnylam Pharmaceuticals
ALNY
$58.5B
| $19M | 0.77% | 300,000 +95,000 | +46% | +$6M |
|
|
IMGN
8
DELISTED
Immunogen Inc
IMGN
| $17.8M | 0.72% | 1,500,000 +200,000 | +15% | +$2.37M |
|
9
Nektar Therapeutics
NKTR
$568M
| $17.3M | 0.7% | 1,350,000 +50,000 | +4% | +$641K |
|
|
10
Amazon
AMZN
$2.44T
| $16.2M | 0.66% | +50,000 | New | +$16.2M |
|
|
11
Ionis Pharmaceuticals
IONS
$6.79B
| $15.7M | 0.63% | 455,000 +355,000 | +355% | +$12.2M |
|
|
ACOR
12
DELISTED
Acorda Therapeutics, Inc.
ACOR
| $14.3M | 0.58% | 425,000 +75,000 | +21% | +$2.53M |
|
13
Citigroup
C
$178B
| $14.1M | 0.57% | 300,000 | – | – |
|
|
ARRY
14
DELISTED
Array Biopharma Inc
ARRY
| $13.7M | 0.55% | 3,000,000 | – | – |
|
15
General Motors
GM
$55.8B
| $12.7M | 0.51% | 350,000 | – | – |
|
|
AVNR
16
DELISTED
AVANIR PHARMACEUTICALS, INC CL A
AVNR
| $11.3M | 0.46% | 2,000,000 +1,100,000 | +122% | +$6.2M |
|
17
Aptiv
APTV
$17.3B
| $10.3M | 0.42% | 150,000 | – | – |
|
|
BLUE
18
DELISTED
bluebird bio
BLUE
| $9.64M | 0.39% | 250,000 +100,000 | +67% | +$3.86M |
|
19
Terex
TEX
$3.28B
| $8.22M | 0.33% | 200,000 +150,000 | +300% | +$6.17M |
|
20
Agios Pharmaceuticals
AGIO
$2.19B
| $8.02M | 0.32% | 175,000 +75,000 | +75% | +$3.44M |
|
|
CERE
21
DELISTED
CERES, INC. COMMON STOCK NEW
CERE
| $5.49M | 0.22% | 8,192,167 | – | – |
|
22
American International
AIG
$45.1B
| $5.46M | 0.22% | +100,000 | New | +$5.46M |
|
|
CMCSK
23
DELISTED
COMCAST CORP SPL A (NEW)
CMCSK
| $5.33M | 0.22% | 100,000 +25,000 | +33% | +$1.33M |
|
24
Aramark
ARMK
$10.3B
| $5.18M | 0.21% | +200,000 | New | +$5.18M |
|
25
Neogen
NEOG
$1.25B
| $5.06M | 0.2% | 125,000 +75,000 | +150% | +$3.04M |
|